1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Medtecs International Corporation Ltd.

Medtecs International Corporation Ltd.

0.11
SGD
+0.00
(-3.51%)
63.21MMarket Cap
Mar 01Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.13
0.12
0.13
0.1
0.11
0.12
0.13
0.73
0.26
0.1
0.1
0.1
0.14
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
0.24
0.03
-0.05
-0.04
-0.04
-0.01
- -
Free Cash Flow per Basic Share
0.01
0.02
0.01
- -
- -
- -
- -
0.17
0.03
-0.03
-0.03
- -
-0.02
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
0.01
0.04
0.01
- -
- -
- -
- -
Book Value per Share
0.12
0.12
0.11
0.11
0.11
0.11
0.12
0.35
0.34
0.27
0.24
0.19
0.19
0.19
Tangible Book Value per Share
0.12
0.12
0.11
0.11
0.11
0.11
0.11
0.35
0.34
0.27
0.23
0.19
0.18
0.18
Basic Weighted Avg Shares
435
446
485
549
549
549
549
549
547
545
545
545
545
545
Sales/Revenue/Turnover
56
52
62
58
62
68
69
400
144
56
53
54
79
- -
Operating Margin (%)
3.76
2.2
5.07
4.14
3.99
3.84
4.62
34.08
11.59
-57.68
-46.66
-51.53
-7.92
- -
Depreciation Expense
4
4
4
3
5
5
6
8
7
6
7
8
7
- -
Net Income, GAAP
1
- -
1
1
1
1
1
132
17
-29
-21
-22
-5
- -
Effective Tax Rate (%)
32.16
66.76
68.62
34.72
8.59
22.93
23.14
2.5
2.41
- -
- -
- -
- -
- -
Profit Margin (%)
1.1
0.74
0.86
1.77
1.43
1.34
1.68
32.9
12.03
-50.84
-40.02
-41.2
-6.03
- -
Working Capital
22
23
24
25
27
32
34
160
143
85
63
70
33
49
LT Debt
8
4
2
- -
2
6
9
3
6
3
2
2
3
3
Total Equity
57
56
60
62
63
63
65
194
188
152
130
107
102
103
Return on Invested Capital (%)
1.43
0.56
1.08
1.66
2.29
1.99
2.27
77.12
7.44
- -
- -
- -
- -
- -
Return on Capital (%)
1.88
1.02
1.09
2.07
2.3
2.26
2.71
77.91
8.74
- -
- -
- -
- -
- -
Return on Common Equity (%)
1.14
0.7
0.92
1.7
1.44
1.47
1.85
102.48
9.16
-17.07
-15.1
-19.05
-4.59
- -

Capital Structure

USD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
19
18
18
LT Borrowings
- -
- -
- -
LT Finance Leases
2
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
545
545
545
Market Capitalization
54
50
49

Working Capital

USD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
79
73
73
Cash, Cash Equivalents & STI
20
19
23
Accounts Receivable, Net
21
19
14
Inventories
30
28
24
Total Current Liabilities
31
40
24
Payables & Accruals
- -
- -
- -
ST Debt
19
18
18
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.85%
-11.85%
-4.32%
Free Cash Flow
-4,621.18%
77.75%
795.74%
Net Income, GAAP
1,089.43%
-90.07%
-78.75%
Sales/Revenue/Turnover
40.98%
-16.58%
45.1%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
54
2025
- -
- -
79
2026
- -
- -
- -

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.04
2025
- -
- -
-0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Weiyuan Yang
Full Time Employees
3,601
Sector
Health technology
Industry
Medical specialties
Address
No. 9, Songgao Road Taipei TP Taiwan 110
IPO Date
Oct 6, 1999
Website
medtecs.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Medtecs International Corporation Limited operates as an integrated provider of healthcare products and services, recognized as a prominent global supplier and distributor of personal protective equipment (PPE) and logistics support for healthcare institutions. Established in 1989 and headquartered in Taipei, Taiwan, the company's operations are distinctly segmented across manufacturing, hospital services, and distribution. The Manufacturing division focuses on producing an extensive array of medical consumables and PPE. This includes items such as diverse surgical masks, various levels of isolation gowns, protective coveralls, patient apparel, underpads, adult diapers, bed linens, and medical bandages. Notably, Medtecs has introduced innovative lines like Medtecs Shield, featuring anti-viral products utilizing nanotechnology. The company has diversified production facilities across Asia, including the Philippines, Cambodia, and China, with a recent joint venture in Cambodia for an FDA-certified nitrile glove factory to enhance its global supply capabilities. Within its Hospital Services segment, Medtecs delivers comprehensive "3L" services: linen leasing, laundry services, and logistics support, catering to hospitals in regions like Taiwan and the Philippines. This segment also extends to managing hospital laundry facilities and other non-core hospital functions. The Distribution segment is responsible for marketing both Medtecs-branded medical consumables and a selection of other medical supplies and equipment, such as wheelchairs and blood pressure monitors. This reach extends to hospitals, pharmacies, and various end-users throughout the Asia Pacific, with a significant global presence serving healthcare distributors, pharmaceutical companies, and national health institutions across the United States, Europe, and Asia Pacific. The company is also expanding into the longevity industry, focusing on home health products and medical devices for an aging demographic. Medtecs maintains a strong commitment to sustainable manufacturing, supported by ISO 14001 and ISO 14064 certifications.